Profile data is unavailable for this security.
About the company
AnGes, Inc., formerly AnGes MG, Inc., is a Japan-based company mainly engaged in the development of genetic medicines. The Company is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of December 31, 2012, the Company had four consolidated subsidiaries. On January 31, 2013, the Company sold a 95.3% stake of a Osaka-based subsidiary to ISHIHARA SANGYO KAISHA LTD.
- Revenue in JPY (TTM)449.34m
- Net income in JPY-6.11bn
- Incorporated1999
- Employees145.00
- LocationAnGes IncSaito Bio-Incubator, 7-7-15, Saito-AsagiIBARAKI-SHI 567-0085JapanJPN
- Phone+81 357302641
- Websitehttps://www.anges.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Linical Co Ltd | 12.15bn | 252.44m | 9.85bn | 662.00 | 35.61 | 1.10 | 12.51 | 0.8103 | 11.18 | 11.18 | 538.03 | 362.32 | 0.6633 | -- | 3.45 | 18,356,870.00 | 1.38 | 4.01 | 2.37 | 6.33 | 29.26 | 30.99 | 2.08 | 5.48 | -- | -- | 0.2518 | 50.81 | -1.67 | 1.70 | -66.32 | -9.86 | -10.18 | 4.56 |
| OncoTherapy Science, Inc. | 562.70m | -1.19bn | 10.87bn | 54.00 | -- | 14.31 | -- | 19.31 | -5.39 | -5.39 | 2.55 | 2.80 | 0.4431 | 5.18 | 15.94 | 10,420,280.00 | -93.70 | -55.67 | -129.70 | -63.82 | -30.63 | -1.49 | -211.47 | -247.47 | 2.67 | -255.18 | 0.1146 | -- | -46.24 | 16.81 | -15.15 | -- | -48.33 | -- |
| 3-D Matrix Ltd | 5.25bn | -1.05bn | 11.50bn | 106.00 | -- | 10.20 | -- | 2.19 | -12.89 | -12.89 | 66.88 | 11.66 | 0.8559 | 0.551 | 5.40 | 49,502,420.00 | -17.15 | -42.10 | -21.31 | -55.60 | 68.38 | 53.95 | -20.04 | -96.03 | 2.51 | -- | 0.7979 | -- | 98.30 | 69.41 | 89.55 | -- | -30.34 | -- |
| Tsubota Laboratory Inc | 674.29m | -691.35m | 11.69bn | 7.00 | -- | 9.80 | -- | 17.34 | -27.06 | -27.06 | 26.38 | 46.62 | 0.2974 | 1.83 | 465.35 | 96,327,430.00 | -30.50 | -- | -42.97 | -- | 7.89 | -- | -102.53 | -- | 2.20 | -434.24 | 0.085 | -- | -29.45 | -- | -811.14 | -- | -- | -- |
| Medinet Co Ltd | 759.11m | -1.34bn | 11.90bn | 98.00 | -- | 2.22 | -- | 15.68 | -5.53 | -5.53 | 3.10 | 20.31 | 0.1347 | 11.64 | 3.73 | 7,745,980.00 | -23.85 | -21.05 | -24.99 | -22.47 | 17.78 | 28.75 | -177.09 | -135.40 | 18.90 | -- | 0.00 | -- | 4.40 | -7.90 | -14.66 | -- | -17.67 | -- |
| Nano Mrna Co Ltd | 76.60m | -650.31m | 13.77bn | 18.00 | -- | 4.21 | -- | 179.79 | -9.24 | -9.24 | 1.09 | 46.27 | 0.0145 | 24.08 | 1.45 | 4,255,556.00 | -12.33 | -24.16 | -13.57 | -25.17 | 78.30 | 84.69 | -848.97 | -600.70 | 9.24 | -- | 0.2540 | -- | -32.98 | -22.88 | 40.50 | -- | -- | -- |
| PRISM BioLab Co Ltd | -100.00bn | -100.00bn | 16.72bn | 22.00 | -- | 7.01 | -- | -- | -- | -- | -- | 66.29 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -79.63 | -- | -822.18 | -- | -- | -- |
| AnGes Inc | 449.34m | -6.11bn | 19.14bn | 145.00 | -- | 0.7267 | -- | 42.59 | -29.92 | -29.92 | 2.22 | 107.33 | 0.0139 | 0.1931 | 4.02 | 3,098,862.00 | -18.95 | -28.50 | -22.32 | -33.14 | 38.79 | 39.42 | -1,359.35 | -6,726.82 | 1.19 | -- | 0.013 | -- | 128.13 | -24.17 | 49.45 | -- | 12.11 | -- |
| Healios KK | 522.00m | -5.39bn | 21.72bn | 64.00 | -- | 6.69 | -- | 41.61 | -68.16 | -68.16 | 6.56 | 36.00 | 0.0321 | -- | 1.61 | 8,156,250.00 | -33.11 | -23.55 | -49.17 | -28.52 | 85.06 | -- | -1,030.65 | -6,580.16 | -- | -1.49 | 0.7469 | -- | 34.44 | -- | 26.04 | -- | -22.00 | -- |
| Pharma Foods International Co., Ltd. | 62.15bn | 3.21bn | 25.62bn | 670.00 | 7.76 | 2.13 | 6.23 | 0.4122 | 113.47 | 113.47 | 2,185.12 | 412.69 | 1.71 | 2.10 | 14.00 | -- | 8.81 | 8.63 | 25.38 | 22.06 | 78.45 | 80.64 | 5.16 | 4.13 | 0.8875 | 81.16 | 0.5932 | 26.28 | -9.37 | 42.62 | 4.02 | 45.01 | 28.23 | -- |
Data as of Sep 20 2024. Currency figures normalised to AnGes Inc's reporting currency: Japanese Yen JPY
0.62%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Simplex Asset Management Co., Ltd.as of 05 Sep 2024 | 1.22m | 0.51% |
| SSgA Funds Management, Inc.as of 05 Sep 2024 | 112.50k | 0.05% |
| Dimensional Fund Advisors LPas of 31 Jul 2024 | 80.10k | 0.03% |
| SPARX Asset Management Co., Ltd.as of 10 Mar 2023 | 40.30k | 0.02% |
| Dimensional Fund Advisors Ltd.as of 05 Sep 2024 | 30.11k | 0.01% |
| BlackRock Investment Management (UK) Ltd.as of 31 Jul 2023 | 0.00 | 0.00% |
More ▼
Data from 28 Jun 2024 - 12 Sep 2024Source: FactSet Research Systems Inc.
